SIC 2835 – In Vitro and In Vivo Diagnostic Substances
Valuation | |
---|---|
Market Cap ($M) | 20.35 |
Enterprise Value ($M) | 16.05 |
Book Value ($M) | 25.59 |
Book Value / Share | 3.09 |
Price / Book | 0.80 |
NCAV ($M) | -38.60 |
NCAV / Share | -4.67 |
Price / NCAV | -0.53 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.98 |
Return on Assets (ROA) | -0.34 |
Return on Equity (ROE) | -0.64 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.49 |
Current Ratio | 1.49 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 10.70 |
Assets | 74.89 |
Liabilities | 49.30 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 1.50 |
Operating Income | -22.86 |
Net Income | -27.78 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -23.32 |
Cash from Investing | -0.93 |
Cash from Financing | 12.19 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Bio-rad Laboratories, Inc. | 8.99 | ||
13D/A | Broadwood Partners, L.p. | 37.60 | -91.11 | |
13G/A | Pura Vida Investments, Llc | 8.45 | -95.74 | |
13G/A | AWM Investment Company, Inc. | 9.10 | -89.60 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
2,057 | 26,020 | 7.91 | |
7,142 | 4,172 | 171.19 | |
4,651 | 2,857 | 162.79 | |
15,236 | 17,084 | 89.18 | |
(click for more detail) |
Similar Companies | |
---|---|
OCEA – Ocean Biomedical, Inc. | OCGN – Ocugen, Inc. |
OCUP – Ocuphire Pharma, Inc. | OKYO – OKYO Pharma Limited |
ONCO – Onconetix, Inc. |
Financial data and stock pages provided by
Fintel.io